相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
Yan Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
Barbara Muz et al.
BLOOD CANCER JOURNAL (2019)
The bone metastasis niche in breast cancer: potential overlap with the haematopoietic stem cell niche in vivo
Gloria Allocca et al.
JOURNAL OF BONE ONCOLOGY (2019)
AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1/CXCR4 signaling pathway in prostate cancer
Wen-Bin Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing
Richard Meeson et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2019)
CXCL12γ Promotes Metastatic Castration-Resistant Prostate Cancer by Inducing Cancer Stem Cell and Neuroendocrine Phenotypes
Younghun Jung et al.
CANCER RESEARCH (2018)
Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling
Andrea Mancini et al.
TUMOR BIOLOGY (2018)
E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271
A. Natoni et al.
LEUKEMIA (2017)
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
Giovanni Luca Gravina et al.
ONCOTARGET (2017)
Selectin catch-bonds mechanotransduce integrin activation and neutrophil arrest on inflamed endothelium under shear flow
Vasilios A. Morikis et al.
BLOOD (2017)
The global decrease in cancer mortality: trends and disparities
D. Hashim et al.
ANNALS OF ONCOLOGY (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Inhibition of E-selectin expression on the surface of endothelial cells inhibits hepatocellular carcinoma growth by preventing tumor angiogenesis
Patrick Borentain et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
M. Katie Conley-LaComb et al.
MOLECULAR CANCER (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
Bioluminescence-Based Tumor Quantification Method for Monitoring Tumor Progression and Treatment Effects in Mouse Lymphoma Models
Jeremie Cosette et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Dual E-Selectin/CXCR4 Antagonist GMI-1359 Exerts Efficient Anti-Leukemia Effects in a FLT3 ITD Mutated Acute Myeloid Leukemia Patient-Derived Xenograft Murine Model
Weiguo Zhang et al.
BLOOD (2016)
A Phase I/II Study of GMI-1271, a Novel E-Selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Elderly Previously Untreated Acute Myeloid Leukemia; Results to Date
Daniel J. DeAngelo et al.
BLOOD (2016)
Mouse models for studying prostate cancer bone metastasis
Jinlu Dai et al.
BONEKEY REPORTS (2016)
Castration-Resistant Prostate Cancer: AUA Guideline Amendment
Michael S. Cookson et al.
JOURNAL OF UROLOGY (2015)
GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
Styliani Karanika et al.
MOLECULAR CANCER (2015)
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models
Giovanni Luca Gravina et al.
PROSTATE (2015)
A Furan-Based Lewis-Y-(CD174)-Saccharide Mimetic Inhibits Endothelial Functions and In Vitro Angiogenesis
Sandra Sauer et al.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2015)
The association of CXCR4 expression with clinicopathological significance and potential drug target in prostate cancer: a meta-analysis and literature review
Qi Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer
Yun Luo et al.
ONCOTARGET (2015)
Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial-to-mesenchymal transition in colon and breast cancers
Venkat R. Katkoori et al.
ONCOTARGET (2015)
Inhibition of microvesiculation sensitizes prostate cancer cells to chemotherapy and reduces docetaxel dose required to limit tumor growth in vivo
Samireh Jorfi et al.
SCIENTIFIC REPORTS (2015)
XPO1/CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce tumor spreading and improve overall survival in preclinical models of prostate cancer (PCa)
Giovanni Luca Gravina et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2014)
CAF-Secreted Annexin A1 Induces Prostate Cancer Cells to Gain Stem Cell-like Features
Lauren A. Geary et al.
MOLECULAR CANCER RESEARCH (2014)
Inhibition of Angiogenesis, Fibrosis and Thrombosis by Tetramethylpyrazine: Mechanisms Contributing to the SDF-1/CXCR4 Axis
Xiaoxiao Cai et al.
PLOS ONE (2014)
Platelets, Selectins, and the Control of Tumor Metastasis
Lucy A. Coupland et al.
SEMINARS IN ONCOLOGY (2014)
Metastasis review: from bench to bedside
Ali Mohammad Alizadeh et al.
TUMOR BIOLOGY (2014)
CXCL12/CXCR4 signaling counteracts docetaxel-induced microtubule stabilization via p21-activated kinase 4-dependent activation of LIM domain kinase 1
Arun Bhardwaj et al.
ONCOTARGET (2014)
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
Donald Wong et al.
BMC UROLOGY (2014)
Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer
Joo Yong Lee et al.
WORLD JOURNAL OF MENS HEALTH (2014)
Human fucosyltransferase 6 enables prostate cancer metastasis to bone
J. Li et al.
BRITISH JOURNAL OF CANCER (2013)
Residual Prostate Cancer Cells after Docetaxel Therapy Increase the Tumorigenic Potential via Constitutive Signaling of CXCR4, ERK1/2 and c-Myc
Koji Hatano et al.
MOLECULAR CANCER RESEARCH (2013)
E-Selectin Mediated Adhesion and Migration of Endothelial Colony Forming Cells Is Enhanced by SDF-1α/CXCR4
Jie Sun et al.
PLOS ONE (2013)
Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1, CXCR4 and VEGF
Guanxiong Ding et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2013)
Association between SDF1-3′A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases
Ferruh K. Isman et al.
MOLECULAR BIOLOGY REPORTS (2012)
CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy
Urszula M. Domanska et al.
NEOPLASIA (2012)
Stromal cell-derived factor-1 enhances distraction osteogenesis-mediated skeletal tissue regeneration through the recruitment of endothelial precursors
Masahito Fujio et al.
BONE (2011)
Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers
Sylvain Julien et al.
CANCER RESEARCH (2011)
Hematopoietic Stem Cell Niche Is a Potential Therapeutic Target for Bone Metastatic Tumors
Yusuke Shiozawa et al.
CLINICAL CANCER RESEARCH (2011)
EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
Nicolas Mottet et al.
EUROPEAN UROLOGY (2011)
MicroRNA-146a and AMD3100, two ways to control CXCR4 expression in acute myeloid leukemias
I. Spinello et al.
BLOOD CANCER JOURNAL (2011)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer (vol 155, pg 231, 2009)
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2010)
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
Claudio Festuccia et al.
ENDOCRINE-RELATED CANCER (2009)
CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
Eugene H. Huang et al.
JOURNAL OF SURGICAL RESEARCH (2009)
Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin
Steven R. Barthel et al.
GLYCOBIOLOGY (2008)
Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies
E. M. Kemper et al.
EUROPEAN JOURNAL OF CANCER (2006)
The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model
M Yang et al.
CLINICAL CANCER RESEARCH (2006)
CXCR4 chemokine receptor mediates prostate tumor cell adhesion through α5 and β3 Integrins
Tobias Engl et al.
NEOPLASIA (2006)
Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients
MD Henry et al.
PROSTATE (2005)
Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein
JL Dai et al.
CANCER RESEARCH (2004)
Osteoblastic cells regulate the haematopoietic stem cell niche
LM Calvi et al.
NATURE (2003)
Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro
DL Lin et al.
PROSTATE (2001)
分享论文
